The Value of Benefit Data in Direct-To-Consumer Drug Ads

Health Affairs - United States
doi 10.1377/hlthaff.w4.234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Health Affairs (Project Hope)

Related search

The Educational Potential of Direct-To-Consumer Prescription Drug Advertising

Health Affairs
MedicineHealth Policy
2004English

Benefit Evaluation of the Value of the Environmental Goods by the Revealed Preference Data. Direct Use Value and Indirect Use Value of Environmental Goods.

Doboku Gakkai Ronbunshu
2002English

Direct-To-Consumer Drug Advertisements Can Paradoxically Increase Intentions to Adopt Lifestyle Changes

Frontiers in Psychology
Psychology
2016English

Trouble Spots in Online Direct-To-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-To-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

International Journal of Health Policy and Management
Health Information ManagementManagementMonitoringHealth PolicyLeadershipHealthPolicyLaw
2016English

Direct-To-Consumer Genetic Testing

British Medical Journal
Medicine
2019English

Direct-To-Consumer Advertising of Pharmaceuticals

American Journal of Medicine
Medicine
2007English

Direct-To-Consumer Genetic Testing

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2009English

Trouble Spots in Online Direct-To-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

International Journal of Health Policy and Management
Health Information ManagementManagementMonitoringHealth PolicyLeadershipHealthPolicyLaw
2015English

Size of the Direct-To-Consumer Genomic Testing Market

Genetics in Medicine
MedicineGenetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy